PVP-Guided Decongestive Therapy in HF 2
Recruiting
Phase 4
Interventional Study
Heart Failure
Congestion
Congestive Heart Failure
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 99
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 650 (estimated)
- Sponsor
- Başakşehir Çam & Sakura City Hospital · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The investigators hypothesize that a simple assessment of peripheral venous pressure (PVP) will better predict the diuretic need and long-term outcomes (all cause mortality, all cause rehospitalization, emergency department visits) compared to standard evaluation.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria
* Hospitalization for heart failure (de novo or decompensated chronic heart failure) irrespective of left ventricular ejection fraction
* Age 18-99
* Accept to participate
Exclusion criteria
* A prior history of upper extremity venous disease
* Serum creatinine ≥ 3.5 mg/dL
* Se…
Contacts